miR-140 Suppresses Tumor Growth and Metastasis of Non-Small Cell Lung Cancer by Targeting Insulin-Like Growth Factor 1 Receptor

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Yuan, Yunfeng ^a   Shen, Yaxing ^a   Xue, Liang ^a   Fan, Hong ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 140; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER INHIBITION; CANCER TISSUE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; LUNG NON SMALL CELL CANCER; MALE; METASTASIS INHIBITION; MOUSE; NONHUMAN; NUDE MOUSE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING;

3' UNTRANSLATED REGIONS; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MICE; MICE, INBRED BALB C; MICE, NUDE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; RECEPTOR, IGF TYPE 1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR BURDEN; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84883804902     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0073604     Document Type: Article

References (29)

1. Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA, (2008) Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment and Survivorship. Mayo Clin Proc 83: 584-594. doi:10.4065/83.5.584. PubMed: 18452692.
2. Tarver T, (2012) Cancer facts & figures 2012. American Cancer Society (Acs) J Consum Health Internet 16: 366-367. doi:10.1080/15398285.2012.701177.
3. Verdecchia A, Francisci S, Brenner H, Gatta G, Micheli A, et al. (2007) Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8: 784-796. doi:10.1016/S1470-2045(07)70246-2. PubMed: 17714993.
4. Bartel DP, (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297. doi:10.1016/S0092-8674(04)00045-5. PubMed: 14744438.
5. Ambros V, (2004) The functions of animal microRNAs. Nature 431: 350-355. doi:10.1038/nature02871. PubMed: 15372042.
6. Kloosterman WP, Plasterk RH, (2006) The diverse functions of microRNAs in animal development and disease. Dev Cell 11: 441-450. doi:10.1016/j.devcel.2006.09.009. PubMed: 17011485.
7. Calin GA, Croce CM, (2006) MicroRNA-Cancer Connection: The beginning of a new tale. Cancer Res 66: 7390-7394. doi:10.1158/0008-5472.CAN-06-0800. PubMed: 16885332.
8. Garzon R, Croce CM, (2008) MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 15: 352-358. doi:10.1097/MOH.0b013e328303e15d. PubMed: 18536574.
9. Ventura A, Jacks T, (2009) MicroRNAs and cancer: short RNAs go a long way. Cell 136: 586-591. doi:10.1016/j.cell.2009.02.005. PubMed: 19239879.
10. Kumar MS, Erkeland SJ, Pester RE, Chen CY, Ebert MS, et al. (2008) Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci U S A 105: 3903-3908. doi:10.1073/pnas.0712321105. PubMed: 18308936.
11. Jusufović E, Rijavec M, Keser D, Korošec P, Sodja E, et al. (2012) let-7b and miR-126 are down-regulated in tumor tissue and correlate with microvessel density and survival outcomes in non--small--cell lung cancer. PLOS ONE 7: e45577. doi:10.1371/journal.pone.0045577. PubMed: 23029111.
12. Schliekelman MJ, Gibbons DL, Faca VM, Creighton CJ, Rizvi ZH, et al. (2011) Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer. Cancer Res 71: 7670-7682. doi:10.1158/0008-5472.CAN-11-0964. PubMed: 21987723.
13. Wang J, Tian X, Han R, Zhang X, Wang X, et al. (2013) Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene. [Epub ahead of print]. PubMed: 23474761.
14. Chen G, Umelo IA, Lv S, Teugels E, Fostier K, et al. (2013) miR-146a inhibits cell growth, cell migration and induces apoptosis in non-small cell lung cancer cells. PLOS ONE 8: e60317. doi:10.1371/journal.pone.0060317. PubMed: 23555954.
15. Liu X, Sempere LF, Ouyang H, Memoli VA, Andrew AS, et al. (2010) MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors. J Clin Invest 120: 1298-1309. doi:10.1172/JCI39566. PubMed: 20237410.
16. Li Y, Zhang D, Chen C, Ruan Z, Li Y, et al. (2012) MicroRNA-212 displays tumor-promoting properties in non-small cell lung cancer cells and targets the hedgehog pathway receptor PTCH1. Mol Biol Cell 23: 1423-1434. doi:10.1091/mbc.E11-09-0777. PubMed: 22357618.
17. Liu XH, Lu KH, Wang KM, Sun M, Zhang EB, et al. (2012) MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5. BMC Cancer 12: 348. doi:10.1186/1471-2407-12-348. PubMed: 22876840.
18. Zhang Y, Eades G, Yao Y, Li Q, Zhou Q, (2012) Estrogen receptor α signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2. J Biol Chem 287: 41514-41522. doi:10.1074/jbc.M112.404871. PubMed: 23060440.
19. Song B, Wang Y, Xi Y, Kudo K, Bruheim S, et al. (2009) Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells. Oncogene 28: 4065-4074. doi:10.1038/onc.2009.274. PubMed: 19734943.
20. Yang H, Fang F, Chang R, Yang L, (2013) MicroRNA-140-5p suppresses tumor growth and metastasis by targeting transforming growth factor β receptor 1 and fibroblast growth factor 9 in hepatocellular carcinoma. Hepatology. [Epub ahead of print]. PubMed: 23401231.
21. Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, et al. (2012) The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61: 278-289. doi:10.1136/gutjnl-2012-302514c.228. PubMed: 21672940.
22. Kong KL, Kwong DL, Chan TH, Law SY, Chen L, et al. (2012) MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 61: 33-42. doi:10.1136/gutjnl-2012-302514a.76. PubMed: 21813472.
23. Croce CM, (2009) Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714. doi:10.1038/nrg2634. PubMed: 19763153.
24. Ryan BM, Robles AI, Harris CC, (2010) Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer 10: 389-402. doi:10.1038/nrc2867. PubMed: 20495573.
25. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269. doi:10.1038/nrc1840. PubMed: 16557279.
26. Chitnis MM, Yuen JS, Protheroe AS, Pollak M, Macaulay VM, (2008) The type 1 insulin-like growth factor receptor pathway. Clin Cancer Res 14: 6364e70. PubMed: 18927274.
27. Zhao X, Dou W, He L, Liang S, Tie J, et al. (2013) MicroRNA-7 functions as an anti-metastatic microRNA in gastric cancer by targeting insulin-like growth factor-1 receptor. Oncogene 32: 1363-1372. doi:10.1038/onc.2012.156. PubMed: 22614005.
28. Kong KL, Kwong DL, Chan TH, Law SY, Chen L, et al. (2012) MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 61: 33-42. doi:10.1136/gutjnl-2012-302514a.76. PubMed: 21813472.
29. Scagliotti GV, Novello S, (2012) The role of the insulin-like growth factor signaling pathway in non-small cell lung cancer and other solid tumors. Cancer Treat Rev 38: 292-302. doi:10.1016/j.ctrv.2011.07.008. PubMed: 21907495.